Loading
UC
Uromed Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Hirsch Capital CORP, was filed 16 Jan 2008.
Uromed Corp: what insiders have been doing
This page follows insider dealings at Uromed Corp as filed with SEC (Form 4). Uromed Corp has had no insider filing for more than a year; the last one goes back to 16 January 2008.
Since 2006, the database holds 1 purchase and 5 sales by insiders of the company.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
7
Thresholds
n/a
Buy Volume
n/a
1 ops. · all time
Sell Volume
€364,408
5 ops. · all time
Last declaration on 16 January 2008
Declarations7 total
00Common StockSEC:0001243875-08-000009:0
Canonical exit: 13 Apr 2008 (T+90)
96,667 shares@ US$0.2516Common StockSEC:0001259951-08-000001:0
91,119 shares@ US$0.2516Common StockSEC:0001262170-07-000004:0
10,000 shares@ US$22.707Series A Prefered StockSEC:0001262170-07-000004:1
90,445 shares@ US$0.2516Common StockSEC:0001262170-07-000005:0
10,000 shares@ US$22.724Series A Preferred StockSEC:0001262170-07-000005:1
2,500,000 shares@ US$0.01Common StockSEC:0001262170-06-000002:0
7 of 7 declarations
About Uromed Corp
Uromed Corp is a company listed on the XNAS market. It specializes in the development of medical products for the treatment of urological disorders.
